Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Cash Flow Reinvestment Rate
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Cash Flow Reinvestment Rate of 5.41x as of June 2025, reinvesting CN¥966.92 Million (capex CN¥15.27 Million plus investments CN¥-951.65 Million) from operating cash flow of CN¥178.57 Million. See free cash flow generation of Hubei Jumpcan Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Hubei Jumpcan Pharmaceutical Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Hubei Jumpcan Pharmaceutical Co Ltd.
Annual Cash Flow Reinvestment Rate for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Hubei Jumpcan Pharmaceutical Co Ltd. See Hubei Jumpcan Pharmaceutical Co Ltd (600566) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥976.87 Million | CN¥1.20 Billion | CN¥95.86 Million | ▼ -13.1% |
| 2024 | 0.94x | CN¥2.04 Billion | CN¥2.18 Billion | CN¥174.34 Million | ▲ +366.7% |
| 2023 | 0.20x | CN¥695.87 Million | CN¥3.46 Billion | CN¥301.64 Million | ▼ -67.6% |
| 2022 | 0.62x | CN¥1.62 Billion | CN¥2.62 Billion | CN¥243.66 Million | ▲ +62.3% |
| 2021 | 0.38x | CN¥723.21 Million | CN¥1.89 Billion | CN¥248.32 Million | ▼ -55.4% |
| 2020 | 0.86x | CN¥1.53 Billion | CN¥1.78 Billion | CN¥429.63 Million | ▲ +189.4% |
| 2019 | 0.30x | CN¥635.44 Million | CN¥2.15 Billion | CN¥546.44 Million | ▼ -51.1% |
| 2018 | 0.61x | CN¥1.03 Billion | CN¥1.71 Billion | CN¥668.06 Million | ▼ -40.5% |
| 2017 | 1.02x | CN¥1.21 Billion | CN¥1.19 Billion | CN¥746.25 Million | ▲ +106.5% |
| 2016 | 0.49x | CN¥449.49 Million | CN¥913.10 Million | CN¥323.49 Million | ▼ -41.8% |
| 2015 | 0.85x | CN¥545.98 Million | CN¥645.48 Million | CN¥395.98 Million | ▲ +72.8% |
| 2014 | 0.49x | CN¥301.51 Million | CN¥616.11 Million | CN¥301.51 Million | ▼ -48.0% |
| 2013 | 0.94x | CN¥270.10 Million | CN¥287.16 Million | CN¥270.10 Million | ▼ -43.1% |
| 2012 | 1.65x | CN¥44.67 Million | CN¥27.01 Million | CN¥44.67 Million | ▼ -98.9% |
| 2011 | 147.69x | CN¥60.74 Million | CN¥411.24K | CN¥60.74 Million | ▲ +9770.9% |
| 2010 | 1.50x | CN¥76.50 Million | CN¥51.13 Million | CN¥76.50 Million | ▲ +2.4% |
| 2009 | 1.46x | CN¥7.19 Million | CN¥4.92 Million | CN¥7.19 Million | ▲ +304.4% |
| 2008 | 0.36x | CN¥8.33 Million | CN¥23.05 Million | CN¥8.33 Million | ▲ +69.4% |
| 2007 | 0.21x | CN¥7.83 Million | CN¥36.72 Million | CN¥7.83 Million | ▼ -98.3% |
| 2006 | 12.22x | CN¥51.83 Million | CN¥4.24 Million | CN¥51.83 Million | ▲ +1194.8% |
| 2005 | 0.94x | CN¥59.80 Million | CN¥63.38 Million | CN¥59.80 Million | ▼ -94.7% |
| 2003 | 17.83x | CN¥39.99 Million | CN¥2.24 Million | CN¥39.99 Million | ▲ +235.0% |
| 2002 | 5.32x | CN¥117.09 Million | CN¥22.00 Million | CN¥117.09 Million | ▼ -55.1% |
| 2001 | 11.86x | CN¥88.07 Million | CN¥7.43 Million | CN¥88.07 Million | ▲ +1349.6% |
| 2000 | 0.82x | CN¥19.41 Million | CN¥23.73 Million | CN¥19.41 Million | — |